What to expect from genetic carrier screening for a BRCA gene mutation

Testing looks for specific inherited changes in BRCA1 and BRCA2. A positive result may indicate an inherited cancer-predisposition change and can affect discussions about personal screening and family testing. A negative result may be reassuring but does not remove every cancer risk. Sometimes the laboratory reports a variant whose meaning is not yet clear; your counsellor can explain why that result does not guide decisions in the same way as a confirmed harmful change.

Before sampling, review your personal and family history, including cancer types and ages at diagnosis where known. Ask what genes the panel includes, how results will be returned, who can access them, and whether relatives may benefit from the information. You normally do not need special preparation for a saliva or blood sample. Arrange time to discuss the result rather than receiving it without support.

Screening itself is not an emergency. Contact the genetics team if a result causes distress, if you are unsure which screening appointment to arrange, or if family members ask questions you cannot answer. Seek prompt clinical advice for any new breast, ovarian, prostate, or pancreatic symptom; genetic results do not replace assessment of symptoms.

Ask whether testing covers BRCA1, BRCA2, or additional genes; what each possible result could change; and whether testing an affected relative first would be useful. Clarify the timing and method of results, options for relatives, and which specialist will coordinate screening or risk-reduction discussions.